DBDalia Ahmed Bassiouny

Dalia Ahmed Bassiouny

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dalia Ahmed Bassiouny has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Rehab Hegazy

    Dermatology Department, Faculty of Medicine Cairo University Cairo Egypt

    5 shared publications
  • Samia Esmat

    Department of Dermatology Cairo University Cairo Egypt

    5 shared publications
  • Marwa Mohamed Fawzy

    Department of Dermatology, Cairo University, Cairo, Egypt

    3 shared publications
  • Nanis Ragab

    Dermatology Department, Faculty of Medicine Cairo University Cairo Egypt

    3 shared publications
  • Dalia AbdelHalim

    The Department of Dermatology, Kasr El‐Ainy Teaching Hospital, Faculty of Medicine Cairo University Cairo Egypt

    2 shared publications
  • Heba Gawdat

    The Department of Dermatology, Kasr El‐Ainy Teaching Hospital, Faculty of Medicine Cairo University Cairo Egypt

    2 shared publications

Latest Publications

  • Proceeding Report of the Sixth Vitiligo International Symposium—December 13–15, 2024, Cairo, Egypt

    by Samia Esmat, Marwa Abdallah, Dalia Bassiony, Lamia H. Elgarhy, Rania M. Mogawer

    This article highlights the most recent updates in vitiligo that were presented in the sixth Vitiligo International Symposium, which was held in Cairo, Egypt from 13 to 15 December 2024. During this conference, worldwide vitiligo experts shared their experience in the different aspects of vitiligo, starting with vitiligo pathogenesis and all the basic science behind vitiligo, going forward to the different assessment tools, including artificial intelligence, and the different therapeutic modalities including new therapeutic targets. Epidemiology and quality of life, along with a dedicated session for people with vitiligo, were included as well. A session for clinical cases was also held this year in which different challenging cases with vitiligo and vitiligo mimickers were presented.

  • Open Access

    Exploring the hair follicle immune privilege state in nonsegmental vitiligo

    by Tag Anbar, Dalia A. Bassiouny, Marwa M. Fawzy, Zeinab El Maadawi, Mai M. Sewelam, Nesreen M.M. Aboraia

    Background: The pathogenesis of nonsegmental vitiligo (NSV) and alopecia areata (AA) overlap in several aspects. In AA, the anagen hair follicle (HF) undergoes a collapse of immune privilege (IP). No previous studies assessed the IP of the HF in NSV. Objective: To assess the IP in NSV compared with AA. Patients and methods: Twenty NSV with scalp lesions and 20 scalp AA patients were included in this prospective comparative study. Clinical assessment and immunohistochemical examination of punch biopsies from lesional and nonlesional scalp were done for interferon gamma (IFN-γ), transforming growth factor beta 1 (TGF-β1), major histocompatibility complex (MHC)I, and MHCII in the HF and epidermis. Results: In AA, there was upregulation of IFN-γ and MHCI and downregulation of TGF-β1 denoting impaired IP in lesional compared with nonlesional HF. In NSV, no difference in IFN-γ was found between lesional and nonlesional HF. MHCI and MHCII were upregulated in lesional HF, while TGF-β1 was significantly lower in lesional HF. A significantly higher expression of IFN-γ and MHCI was detected in lesional epidermis compared with lesional HF in NSV patients. Lesional HF in AA showed significantly higher expression of IFN-γ and MHCI and significantly lower expression of TGF-β1 than lesional HF in NSV, denoting preserved IP in NSV. Conclusion: IP is preserved in HF in NSV compared with AA, protecting the follicular melanocytes from autoimmune attacks.

  • Value of silicone gel in prevention of cobblestoning following punch minigrafting in vitiligo

    by Tag Anbar, Talal Abd El Raheem, Dalia Ahmed Bassiouny, Marwa Mohamed Fawzy, Zeinab El Maadawi, Noha Farouk, Mohamed Hassan

    Background: Cobblestoning is the most common complication of minipunch grafting. Objective: To assess the value of silicone gel application following minipunch grafting and the histopathological and immunohistochemical changes in cases with cobblestoning. Methods: Minipunch grafting was performed in two similar vitiligo lesions in 27 cases with stable vitiligo. After healing, silicone gel was applied twice daily on one lesion while zinc oxide ointment was applied to the other lesion serving as a control. Four biopsies were taken from each case; normal, vitiliginous skin before treatment and the two treated lesions 3 months after therapy, for histopathology and immunohistochemical staining for MMP9 & tenascin-C. Results: Repigmentation occurred in 19 cases (70.7%). The number of lesions showing excellent and good response was significantly higher on the silicone gel side (p < .001). In 20 cases, cobblestoning either occurred or was absent on both sides. Histopathologically, cobblestoning was similar to hypertrophic scarring. Both markers were elevated after therapy on both sides with no significant difference in percentage change between lesions showing positive and negative cobblestoning. Conclusion: Silicone gel application after minigrating improved the final response with no significant effect on the occurrence of cobblestoning. Cobblestoning resembled hypertrophic scarring histopathologically.


  • Early localized vitiligo, a medical emergency: Long‐term follow‐up study

    by Samia M. Esmat, Dalia Bassiouny, Rehab Hegazy, Suzan Shalaby, Nanis Ragab, Sarah Ibrahim, Rania M. Mogawer

    Background In spite of multiple therapeutic regimens for vitiligo, disease relapse remains a challenge. Most guidelines consider systemic treatments only in rapidly progressive disease with wider surface areas. This delay in halting the immune attack, may give the chance for further disease progression as well as establishment of resident memory T-cell population predisposing to future relapses. Objectives To assess the ability of early systemic therapy of localized (<2% BSA), recent onset (<6 months) vitiligo to control disease activity and minimize the possibility of recurrence. Methods 25 patients with recent onset (<6 months), localized (<2% BSA) vitiligo were included. Patients received pulse dexamethasone therapy for 6 months plus topical treatments and NB-UVB sessions. Patients were followed monthly as regards percent of repigmentation and VIDA score. To detect recurrence, biannual assessment was done for 4 years. Results Eighty-four percent of patients had acrofacial lesions and 44% had facial lesions. Arrest of activity was achieved after 3.65 ± 2.19months. Complete repigmentation was achieved in a mean duration of 6.88 ± 0.2months. At the end of the 4-year follow up, recurrence occurred in 32% of patients. In spite of recurrence; localized disease (<2% BSA) was secured. A significantly higher incidence of recurrence was associated with cases with bilateral distribution of lesions. Conclusion Early systemic immunomodulation for recent localized vitiligo is a successful approach to achieve early control of disease activity and minimize the incidence of recurrence. Such cases should not be overlooked but managed as early as possible; it is a race against time.


  • Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo‐types (III–V): A double‐blind, randomized, placebo‐controlled, prospective, multicenter study

    by Samia M. Esmat, Medhat El‐Mofty, H. Rasheed, Wedad Z. Mostafa, Tag S. Anbar, Marwa Abdallah, Dalia Bassiouny, Dalia Abdel‐Halim, Rehab Hegazy, Amira Abulfotooh Eid, et al.

    Background: NB‐UVB has long been the vitiligo management pillar with capability of achieving the main treatment outcomes; repigmentation and stabilization. Its stabilizing effect in dark skin has been debatable. However, randomized controlled trials regarding NB‐UVB ability to control disease activity are lacking.Purpose: To assess stabilizing effect of NB‐UVB in comparison to systemic corticosteroids, the mainstay in vitiligo stabilization, in skin photo‐types (III‐V).Methods: This is a multicenter, placebo‐controlled, randomized, prospective study. Eighty patients with active nonsegmental vitiligo (NSV) (Vitiligo disease activity (VIDA) ≥2) were randomized to either NB‐UVB and placebo (NB‐placebo) or NB‐UVB and dexamethasone oral mini‐pulse (OMP) therapy (NB‐OMP) for 6 months. Sixty four patients completed the study, 34 in the NB‐OMP group and 30 in the NB‐placebo group. Patients were evaluated fortnightly according to presence or absence of symptoms/signs of activity.Results: In spite of earlier control of disease activity observed in the NB‐OMP group, it was comparable in both groups by the end of the study period. Disease activity prior to therapy, but not extent, was found to influence control of activity in both groups. Thus, NB‐UVB is a safe sole therapeutic tool in vitiligo management. Not only does it efficiently achieve repigmentation, but also it is a comparable stabilizing tool for systemic corticosteroids in spite of slightly delayed control.Conclusion: NB‐UVB is the only well‐established vitiligo therapy that can be used solely whenever corticosteroids are contraindicated or immune‐suppression is unjustified. Nonetheless, its combination with corticosteroids expedites response and improves compliance.


  • Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study

    by Marwa El Hawary, Dalia Ahmed Bassiouny, Samia Esmat, Rehab Sobhi, Marwah Adly Saleh, Dalia AbdelHalim, Rehab Hegazy, Heba Gawdat, Nanis Ragab, Nesrin Samir, et al.

    Surgical treatment of vitiligo lesions over the fingers has poor outcome. Three variations were used in treatment of finger vitiligo lesions: minipuch grafting, melanocytes keratinocyte transplantation procedure (MKTP) preceded by cryoblebbing or full CO2 laser resurfacing of the recipient site. An intra‐patient comparative study including 12 patients with stable non‐ segmental vitiligo (NSV) affecting the middle 3 fingers of one hand. Liquid nitrogen was used to create blebs in one finger 24 hours before therapy. On the following day, the second finger was treated by minipunch grafting and the third finger was resurfaced by CO2 laser. A suspension was prepared and 0.1 mL was injected into each cryobleb. It was also applied to the resurfaced skin. All patients underwent topical PUVA therapy and were followed‐up for 12 months. Ten cases with 52 lesions completed the follow‐up period. 4/18 lesions treated by cryoblebbing followed by MKTP showed ≥75% repigmentation while only 1/17 lesions treated by laser resurfacing + MKTP and 1/ 17 lesions treated by minipunch grafting showed 30%and 10% repigmentation respectively. No complications occurred in MKTP treated lesions. Cryoblebbing of the recipient site seems to improve the outcome of MKTP in lesions over the fingers in stable NSV.


  • Cosmetic camouflage as an adjuvant to vitiligo therapies: Effect on quality of life

    by Dalia Bassiouny, Rehab Hegazy, Samia Esmat, Heba I. Gawdat, Marwa Ahmed Ezzat, Hebat‐Allah Tawfik, Amira Aly Hegazy, Sarah Ibrahim

    Background: Vitiligo is a pigmentary disorder associated with considerable psychological imbalance. Partial response to therapy and long duration for repigmentation are common. Meanwhile, camouflage may help through concealing vitiligo lesions and improving patient confidence and self‐esteem.Aim: To assess the Dermatology Life Quality Index (DLQI) in vitiligo patients, and to determine the patients’ acceptance and willingness to utilize camouflage regularly and the impact of using camouflage as an adjuvant modality.Patients/Methods: The study was carried out on 100 vitiligo patients who underwent thorough history taking, clinical examination, and DLQI assessment. Forty patients were randomly chosen, taught how to apply camouflage, and followed up over 1 month of regular application.Results: Dermatology Life Quality Index in the 100 vitiligo patients was found to be 12.2 ± 3.9, denoting the very large effect on quality of life vitiligo has. It was significantly worse in female patients, adolescents, students, and high‐socioeconomic level patients, in visible sites and genitalia, and in unstable cases. There was a significant positive correlation between the DLQI and disease duration (r = 0.75, P < .001) and VES (r = 0.79, P < .001). The 40 cases on camouflage showed a significant percent reduction in their DLQI when compared to noncamouflage users (P: .00).Conclusions: Dermatology Life Quality Index is significantly affected by vitiligo. Camouflaging is a technique that needs to be taught to the patient to overcome the anticipated problems that drive them away from using it; especially, it significantly improves their DLQI in their devastating disease.


  • Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo

    by Samia Esmat, Dalia Bassiouny, Marwah Adly Saleh, Dalia AbdelHalim, Rehab Hegazy, Marwa ElHawary, Heba Gawdat, Heba Gouda, Mervat Khorshied, Nesrin Samir

    Addition of different growth factors to the medium used in autologous melanocyte‐keratinocyte transplantation procedure (MKTP) was reported in literature. Objective: Comparison of response to MKTP in segmental vitiligo (SV) with and without adding growth factors to the suspension medium. 18 cases with SV were randomly divided into 2 groups. Group A: Ham F12 medium was used for suspension and group B: 5 ng/mL recombinant basic fibroblast growth factor (bFGF) and 25 mg /500 mL 3′5’cyclic adenosine monophosphate (cAMP) were added to the medium. All cases received NB‐UVB twice weekly for 24 weeks. The area of vitiligo lesions was measured before and after therapy by point counting technique and complications were recorded. Excellent response (90‐100% repigmentation) occurred in 5/9 cases (56%) in group A and 7/9 cases (78%) in group B (with growth factors). A significant decrease in area of treated lesions before and after therapy was found in both groups A and B (P = 0.0012 & 0.0004 respectively), however a higher percentage of reduction in area of vitiligo was seen in group B cases (70% in group A vs 90% in group B; p value: 0.028). Marginal halo was seen in 5 cases in group A and 6 in group B. Addition of bFGF and cAMP to MKTP medium improved the results of the procedure. It could be considered if economically feasible.


  • Open Access

    Autologous non-cultured melanocyte–keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives

    by Dalia Bassiouny, Samia Esmat

    Autologous non-cultured melanocyte–keratinocyte transplantation procedure (MKTP) is one of the simplest cellular grafting techniques. Various modifications were done over the years to make the technique easier and more economical which led to its great popularity among dermatologists. Proper patient selection and good technical skills are essential for achieving success with this technique. In this review, different patient-related and procedure-related factors that affect the outcome are discussed. This review may guide dermatologists to select suitable candidates, and explains what to expect in each case and indicates different techniques which can be used. The expected complications and stability of acquired pigmentation, which are an essential part of the pretreatment patient counseling, are also discussed.


  • Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open‐label controlled clinical and histopathological study

    by Bakr M El‐Zawahry, Rehab M Sobhi, Dalia A Bassiouny, Sahar A Tabak

    Summary: Introduction: Burn scars can cause permanent disfiguring problems with limited treatments available.Objectives: To assess and correlate the clinical and histopathological effects of fractional CO2 laser on thermal burns in a controlled study.Methods: Fifteen patients 11 with hypertrophic and four with keloidal scars received three CO2 fractional laser sessions every 4–6 weeks. Half of the scar was untreated as a control. Clinical evaluation by Vancouver, PSOAS scores, and photography before, monthly, and 3 months after the last laser session was performed. Ten patients were evaluated histopathologically by standard H&E, Masson trichrome, and Elastica von Gieson special stains.Results: Hypertrophic scars (HTSs) showed textural improvement and a significant decrease of Vancouver, POSAS observer, and patient scores by the end of follow‐up period in the laser‐treated area (P = 0.011, 0.017 and 0.018, respectively) unlike keloidal scars. Histopathology revealed significant decrease in scar thickness in HTSs only (P < 0.001) as well as a significant decrease in collagen bundle thickness and density in the upper dermis in both types of scars.Conclusions: Fractional CO2 laser is a possible safe and effective modality for the treatment of hypertrophic burn scars with improvement achieved both clinically and histopathologically.